Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Seizures 2 Brain Neoplasms 2 beta-Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Seizures After Brain Tumor Surgery 1 Neurofibromatosis 1 1 Neoplasm, Residual 1 Necrosis 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Influenza, Human 1 Hematologic Neoplasms 1 Glioma 1 Chromosome Aberrations 1 Chromosome 7, monosomy 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Magnetic Resonance Spectroscopy 19 Temozolomide 16 Radiotherapy 10 Specimen Handling 7 Blood Specimen Collection 7 Radiation 6 Bevacizumab 5 Nivolumab 4 Cyclophosphamide 4 Biopsy 4 vorasidenib 3 trametinib 3 pembrolizumab 3 olaparib 3 fludarabine 3 dabrafenib 3 Watchful Waiting 3 Surgical Procedures, Operative 3 Magnetic Resonance Imaging 3 Drug Therapy 3 olutasidenib 2 lutetium Lu 177 dotatate 2 fluorodopa F 18 2 fluciclovine F-18 2 entrectinib 2 contrast agent BR1 2 Restraint, Physical 2 Radiosurgery 2 Microdialysis 2 Flucytosine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioma × Levetiracetam × Clear all

NCT03048084 2025-02-04

STING

Leiden University Medical Center

Phase 4 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡